M
10b5-1 Plan
$ Value
$0
Shares
27,280
Price
$0
Filed
Apr 22
Insider
Name
Craig Kevin James
Title
Chief Medical Officer
CIK
0002049601
Roles
Officer
Transaction Details
Transaction Date
2026-04-20
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
706,859
Footnotes
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025. | The stock option vested as to 25% of the underlying shares on January 1, 2026, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter. | The stock option vested as to 25% of the underlying shares on January 1, 2025, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter.
Filing Info
Craig Kevin James's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-20 | ATAI | M | $41K |
| 2026-04-20 | ATAI | M | $28K |
| 2026-04-20 | ATAI | ▼ | $213K |
| 2026-04-20 | ATAI | M | $0 |
| 2026-04-20 | ATAI | M | $0 |
| 2026-03-20 | ATAI | M | $90K |
| 2026-03-20 | ATAI | M | $36K |
| 2026-03-20 | ATAI | ▼ | $355K |
| 2026-03-20 | ATAI | M | $0 |
| 2026-03-20 | ATAI | M | $0 |
Other Insiders at ATAI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Angermayer Christian | — | — | 2026-04-08 |
|
Rao Srinivas
See remarks
|
— | — | 2026-01-30 |
|
Johnson Anne Nagengast
Chief Financial Officer
|
— | — | 2026-01-30 |
|
Kochendoerfer Gerd
Chief Operating Officer
|
— | — | 2026-01-30 |
|
Short Glenn Frank
Chief Scientific Officer
|
— | — | 2026-01-30 |
|
Craig Kevin James
Chief Medical Officer
|
— | $568K | 2026-04-20 |
|
Barrett Christopher Ryan Cave
See remarks
|
— | — | 2026-01-30 |